Immunization for Ebola virus infection. - Wikidata - awgldk - TriplyDB

Immunization for Ebola virus infection.

Immunization for Ebola virus infection.

http://www.wikidata.org/entity/Q34065766

about

Animal models for Ebola and Marburg virus infections Environmental health research in the post-genome era: new fields, new challenges, and new opportunities Ebolavirus vaccines for humans and apes The Role of Cytokines and Chemokines in Filovirus Infection Ebola Virus Disease (The Killer Virus): Another Threat to Humans and Bioterrorism: Brief Review and Recent Updates Mouse models for filovirus infections Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts Overcoming immunity to a viral vaccine by DNA priming before vector boosting Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity Ebola virus can be effectively neutralized by antibody produced in natural human infection.Genes that induce immunity--DNA vaccines.Potential strategies utilised by papillomavirus to evade host immunity.Biochemical analysis of the secreted and virion glycoproteins of Ebola virus.Ebola Vaccine: How Far are we?Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.Infectivity-enhancing antibodies to Ebola virus glycoprotein.Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelope Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates Challenges and opportunities for development of an AIDS vaccine.Ebola virus pathogenesis: implications for vaccines and therapies.Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization.Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial DNA vaccines for biodefense.The multiple roles of sGP in Ebola pathogenesis Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.Hegemonic structure of basic, clinical and patented knowledge on Ebola research: a US army reductionist initiative.Towards a vaccine against Ebola virus.Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines Evaluation in nonhuman primates of vaccines against Ebola virus.

P2860

Q21131118-C3D2975B-0EB5-464A-B743-14ACA693BA71 Q23914178-DAE42A03-AD83-4595-866B-BAB4517D7C03 Q24631696-F43272B1-256A-45ED-AFC5-F64EBBCC2FE1 Q26778003-3FE9B394-03C9-445C-A201-054430E76AE4 Q26798860-F77DB78C-40F1-4980-9FE1-FF822395C25B Q27011569-B1C01962-F8E3-4FE7-8809-851F6C5987F5 Q27486035-BE7FACD7-2002-40FC-ACD3-F1EF6A2CDBDE Q28217213-6FFD9B3C-BAF2-4E73-9918-708F6039687F Q28768041-B12ED8B1-D868-456A-B0EA-28DE6F186AEB Q30307077-22F80313-98D1-4CAE-AEA2-AA57AA3ABAD6 Q30712477-97312D5E-9FC9-4080-88FB-8C6CFF9EFBDA Q33641393-E74FC3F0-C219-4E3A-A4A0-EA6113E1FC14 Q33683360-5596453A-DBBB-48DC-8518-60247C959C71 Q33783398-31760458-7855-4A93-9D6D-0432135EB48B Q33831877-AE850775-40E3-4636-B931-01ED89E9553C Q33840716-A10F312D-7BC2-4569-BB46-0A31A755A2E7 Q33850032-3188C197-E2D5-4931-B9E9-F1790FE1D797 Q33850720-D08A3E3C-9B41-4B25-86EB-26426E25ED17 Q33855682-EE5E17C1-C395-47CA-976B-3158E65F1DB2 Q33865376-C9FA7C27-1FB9-46AF-9D13-2B2BB4372AEE Q33883854-5D064EC8-19E5-43F5-8B2E-D562F492E20B Q33942996-B9440CA5-E626-414A-943A-8EAC989D3546 Q33967985-9D00C08F-B9EC-4E5B-8368-0C42854DB012 Q34123838-BF839544-4EAC-4520-85AE-AE9B7CADA47B Q34123950-E715D7B9-5200-45A7-8A23-36847F042A7F Q34220503-815847D3-DC0D-4517-B631-1641A1E42E9E Q34326453-16691644-A6AD-4BF1-A1AA-51A688476D41 Q34345308-0C30415C-1D2D-452D-BDE0-1F947493D488 Q34363707-8C804A93-B00F-4C93-B54B-CE2F063356C6 Q34434713-9A5FF485-CED0-45D5-BB3D-47EB1E143DF8 Q34440836-11D45D90-5154-48BE-B461-989E45A2C910 Q34571072-674648DF-4BDA-4595-9A2B-8E624E77F0BA Q34614260-6F453850-34A6-4C54-8CBB-0CF899E4BB86 Q34869463-4623B038-0D3D-4A8D-A37A-D47DB562748B Q34971349-30F18AB8-B386-4E93-AF0C-A4480430D0F8 Q35123128-506FBC8D-D837-4B90-A84B-ECFE244EE10C Q35595035-211C1217-A314-4B7D-A451-357A6DB6BCEC Q35623381-BAEA35F9-269C-4B67-ACEF-F214D4709645 Q35635459-D6B0D37E-F9C0-491D-B539-1A700498D73F Q36015461-4EC49EC8-58D2-42B3-A427-158596DE7F5D

P2860

Immunization for Ebola virus infection.

http://www.wikidata.org/entity/Q34065766

description

1998 nî lūn-bûn

@nan

1998 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Immunization for Ebola virus infection.

@ast

Immunization for Ebola virus infection.

@en

Immunization for Ebola virus infection.

@nl

type

label

Immunization for Ebola virus infection.

@ast

Immunization for Ebola virus infection.

@en

Immunization for Ebola virus infection.

@nl

prefLabel

Immunization for Ebola virus infection.

@ast

Immunization for Ebola virus infection.

@en

Immunization for Ebola virus infection.

@nl

P1433

Q34065766-F27A2750-B195-4613-A2F6-9F561B5736BC

P1476

Q34065766-5D083C59-B36A-4A17-A33A-0AFE154129D9

P2093

Q34065766-204E9BB7-6C90-46B1-9C75-18D8CC6F81D7

Q34065766-3AC6A315-1ABF-45CC-900D-D64790559E97

Q34065766-59F36519-8614-4C1D-BCA1-8AEDEAD43DCA

Q34065766-5BA1364A-1113-4136-AB44-08D4A4367585

Q34065766-93ED1110-1513-479B-A367-C924ECEEC01D

Q34065766-CFF44B28-2021-449C-87F5-68329784CFA0

Q34065766-D909BCE0-5B21-4C18-B40E-DC9A541498D6

P2860

Q34065766-18F71F59-A469-4E43-9EDB-909FC8B3C1D0

Q34065766-206FE212-4AA9-4F1B-90CD-155EB251CA98

Q34065766-5429F7DF-4587-415D-A8F4-5282D2788489

Q34065766-6BC08F48-B11F-44E9-92CC-8EC4CE80559A

Q34065766-736C67C5-A2BD-4556-ADC2-9D1A997B4483

Q34065766-9C149EDC-A035-4769-A4C9-606E61A6CE7C

Q34065766-B9FFCF6F-42E9-4977-B54E-63558BD43B72

Q34065766-C11EEC92-B43B-4D0C-BFF6-1CB38FBA5BD6

Q34065766-EB639634-B9EA-4ADD-A69E-F003EB72289D

Q34065766-F09A5FA2-217D-428C-AC25-73ED1BF45125

P2888

Q34065766-2BA36FBD-7CDA-4BE8-8DF1-66681A55BB38

P304

Q34065766-9AC02DE1-C9B4-4B12-ABE0-338E501752D5

P31

Q34065766-35355A37-EC06-4FFB-A8FD-CB62CC0B5FFB

P356

Q34065766-20AE427E-8708-407B-8AD8-731943AD9D6C

P407

Q34065766-0A45189D-B140-4464-95BB-26BBA49A93E8

P433

Q34065766-01788757-0EAE-438D-B6E8-252F38A008FE

P478

Q34065766-1A8352C4-D905-4BCB-83F9-9B231E1D49C7

P577

Q34065766-9CB7FDCA-691C-453D-B110-804F8378EE22

P6179

Q34065766-54F08E90-EEE3-4163-97D8-73E6A9C91096

P698

Q34065766-D90DFC0E-F3EC-410A-9C30-0B7FF222A5EF

P921

Q34065766-82C210B2-1DA7-4C03-9EEA-06294C6AE847

Q34065766-E7AAA964-0AE6-4375-B437-DD6466E59D99

P356

P1433

Nature Medicine

P1476

Immunization for Ebola virus infection.

@en

P2093

Nabel EG

http://www.w3.org/2001/XMLSchema#string

Nabel GJ

http://www.w3.org/2001/XMLSchema#string

Nichol ST

http://www.w3.org/2001/XMLSchema#string

Sanchez A

http://www.w3.org/2001/XMLSchema#string

Xu L

http://www.w3.org/2001/XMLSchema#string

Yang Z

http://www.w3.org/2001/XMLSchema#string

Zaki SR

http://www.w3.org/2001/XMLSchema#string

P2860

Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent.

A molecular model of MHC class-I-restricted antigen processing.

Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus.

The GP-protein of Marburg virus contains the region similar to the 'immunosuppressive domain' of oncogenic retrovirus P15E proteins.

The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses.

The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression.

Biologic differences between strains of Ebola virus from Zaire and Sudan.

Genetic immunization is a simple method for eliciting an immune response.

P2888

P304

37-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM0198-037

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032815221

http://www.w3.org/2001/XMLSchema#string

P698

9427604

http://www.w3.org/2001/XMLSchema#string

P921